From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Part 1: National Hepatitis B Prescriber Forum 2025

Course duration
1 hour
Course Type
On Demand
Course duration
1 hour
Course Type
On Demand

On Friday 28th March 2025, ASHM hosted its third Hepatitis B Prescriber Forum. With expert panels and interactive case discussions, the 2025 Hepatitis B Prescriber Forum was an opportunity to dive deep into emerging areas of hepatitis B treatment and management and discuss the contemporary issues facing hepatitis B clinical care in Australia. The recordings for the forum have been broken into Part 1 and Part 2. This activity is Part 1.

Part 1: National Hepatitis B Prescriber Forum 2025 contains the recordings of the following presentations:

  • New WHO guidelines on hepatitis B care
  • Hepatitis B and pregnancy
  • Co-infection
  • NP prescriber focus

Watching Part 1 you can accrue 1 HBV CPD. For watching both Part 1 and Part 2: National Hepatitis B Prescriber Forum you will accrue a total of 2 HBV CPD.

Go to Part 2: National Hepatitis Prescriber Forum 2025.

The module completion record will be constantly monitored by the ASHM HBV Prescriber Team. If you are an HBV Prescriber, please be advised that HBV CPD points will be uploaded onto the prescriber portal/MyASHM automatically by ASHM staff during the renewal period.

ASHM thanks the Commonwealth Department of health for providing the funding to deliver this forum. ASHM also thanks the range of hepatitis B clinical advisors, speakers, facilitators, and steering committee members who helped bring this forum together.